Globus Medical and NuVasive disclose supplemental proxy info to settle merger lawsuits

GLOBUS MEDICAL INC

Five shareholder complaints filed in March-April 2023 in NY, DE, and Colorado courts alleging incomplete/misleading proxy statement for the merger.
NuVasive and Globus Medical deny merit but are making supplemental disclosures to avoid risk of delaying the merger.
Supplemental disclosures add details: no acquisition proposals received during Window Shop Period (ended March 10, 2023).
Supplemental disclosures also provide additional details on Goldman Sachs and BofA financial analyses, including net debt adjustments and discount rate ranges.
Defendants are not admitting legal necessity or materiality of the supplemental disclosures.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.